EA201892739A1 - METHODS OF TREATMENT OF ALZHEIMER'S DISEASE - Google Patents

METHODS OF TREATMENT OF ALZHEIMER'S DISEASE

Info

Publication number
EA201892739A1
EA201892739A1 EA201892739A EA201892739A EA201892739A1 EA 201892739 A1 EA201892739 A1 EA 201892739A1 EA 201892739 A EA201892739 A EA 201892739A EA 201892739 A EA201892739 A EA 201892739A EA 201892739 A1 EA201892739 A1 EA 201892739A1
Authority
EA
Eurasian Patent Office
Prior art keywords
treatment
alzheimer
disease
methods
subject
Prior art date
Application number
EA201892739A
Other languages
Russian (ru)
Inventor
Брендон Филлип Бут
Джеффри Джозеф Севиньи
Лесли Луджен Уильямс
Original Assignee
Байоджен Интернэшнл Ньюросайенс Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Байоджен Интернэшнл Ньюросайенс Гмбх filed Critical Байоджен Интернэшнл Ньюросайенс Гмбх
Priority claimed from PCT/EP2017/063711 external-priority patent/WO2017211827A1/en
Publication of EA201892739A1 publication Critical patent/EA201892739A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule

Abstract

Представлены способы для лечения болезни Альцгеймера у субъекта-человека, нуждающегося в этом, когда у субъекта развивается связанная с накоплением амилоида аномалия, наблюдающаяся при визуализационных исследованиях (ARIA), во время применения схемы лечения, включающей введение многократных доз антитела к бета-амилоиду (например, BIIB037) субъекту.Methods are presented for the treatment of Alzheimer's disease in a human subject in need thereof, when the subject develops an anomaly associated with amyloid accumulation, which is observed during imaging studies (ARIA), during the application of a treatment regimen involving the administration of multiple doses of antibody to beta-amyloid (for example , BIIB037) to the subject.

EA201892739A 2016-12-16 2017-06-06 METHODS OF TREATMENT OF ALZHEIMER'S DISEASE EA201892739A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662435531P 2016-12-16 2016-12-16
PCT/EP2017/063711 WO2017211827A1 (en) 2016-06-07 2017-06-06 Methods for treating alzheimer's disease

Publications (1)

Publication Number Publication Date
EA201892739A1 true EA201892739A1 (en) 2019-06-28

Family

ID=66998655

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201892739A EA201892739A1 (en) 2016-12-16 2017-06-06 METHODS OF TREATMENT OF ALZHEIMER'S DISEASE

Country Status (1)

Country Link
EA (1) EA201892739A1 (en)

Similar Documents

Publication Publication Date Title
MX2018015022A (en) Methods for treating alzheimer's disease.
CL2019001433A1 (en) Modulators of the core protein of hepatitis b. (divisional request 201800684)
BR112018003984A2 (en) antibodies
EA201791199A1 (en) METHOD OF TREATMENT OF ALZHEIMER'S DISEASE
MX2022007522A (en) Anti-cd27 antibodies.
JOP20170004B1 (en) ANTl-N3pGlu AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF
CL2018002727A1 (en) Medicine obtained by combining agonist fxr and arb
CO2017000346A2 (en) Aβ protofibril binding antibodies
MA46621A (en) COMBINATION TREATMENTS INCLUDING THE ADMINISTRATION OF IMIDAZOPYRAZINONES
CY1119957T1 (en) TREATMENT OF PATIENTS WITH THE USE OF ANNOUNCED PHARMACEUTICAL PREPARATION
EA201790475A1 (en) METHODS OF TREATING SYSTEMIC RED LAMPS USING A DOMAIN ANTIBODY AGAINST CD28
ECSP16084317A (en) PHARMACEUTICAL FORMULATIONS, PREPARATION PROCESSES AND METHODS OF USE
BR112018015367A2 (en) nanofiber oromucosal carriers for therapeutic treatment
EA201691860A1 (en) PEPTIDE MEDICINE AS A DRY POWDER
EA201892265A1 (en) METHODS OF TREATMENT OF OPHTHALMIC DISEASES
MA40535A (en) Hsp90-targeted inflammation and infection imaging and therapy
CO2020005485A2 (en) Oral administration of glp-1 peptide analogs
JOP20220092A1 (en) Anti-beta-amyloid antibody for treating alzheimer's disease
EA201692111A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING DANIRYXIN FOR TREATING INFECTIOUS DISEASES
BR112018010066A2 (en) 5-hydroxytryptamine 1b receptor stimulating agent to enhance in vivo graft potential
MD4763B1 (en) Pharmaceutical composition
EA201700254A1 (en) COMBINATION
EA201892739A1 (en) METHODS OF TREATMENT OF ALZHEIMER'S DISEASE
HK1257598A1 (en) Medicine for improving heart disease and use thereof
EA201692164A1 (en) MEDICINE FOR THE TREATMENT OF PATIENTS WITH TINNITUS